A phase II study of Triapine [OCX 0191] in combination with gemcitabine in patients with metastatic non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2013
At a glance
- Drugs Gemcitabine; OCX 191
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 02 Jan 2008 Status changed from in progress to completed.
- 03 Sep 2005 New trial record.